scispace - formally typeset
L

Linda Giblin

Researcher at Teagasc

Publications -  84
Citations -  3807

Linda Giblin is an academic researcher from Teagasc. The author has contributed to research in topics: Chemistry & Enteroendocrine cell. The author has an hindex of 24, co-authored 76 publications receiving 3339 citations. Previous affiliations of Linda Giblin include Massey University & University College Cork.

Papers
More filters
Journal ArticleDOI

Nucleic acid-based approaches to investigate microbial-related cheese quality defects

TL;DR: The DNA-based methods that are available to detect/quantify spoilage bacteria, and relevant metabolic pathways in cheeses are reviewed and it is highlighted how these strategies can be employed to improve cheese quality and reduce the associated economic burden on cheese processors.
Journal ArticleDOI

A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.

TL;DR: Comparison with two other coexpressed mutant/normal channels suggests that the I4898T mutation produces one of the most abnormal RyR1 channels yet investigated, and this level of abnormality is reflected in the severe and penetrant phenotype of affected central core disease individuals.
Journal ArticleDOI

Bovine β-lactoglobulin/fatty acid complexes: binding, structural, and biological properties.

TL;DR: The structure-function relationships are reviewed in the light of the structural state of the protein (native versus non-native aggregated proteins), and the binding properties of native β-lg (localization of binding sites, stoichiometry, and affinity) and some biological properties of the complexes are addressed.
Journal ArticleDOI

Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype

TL;DR: In this paper, the relative predominance of each of five probiotic strains was investigated in the ileum of weaned pigs, compared with that in feces, when administered in combination at c. 5 x 10(9) CFU day(-1) for 28 days.